Adjuvant chemotherapy with low-dose cisplatin following surgery for malignant tumors in dogs: 16 cases

HYOU3 ―■原著 術後の補助的化学療法として低用量シスプラチン 療法を行った犬の悪性腫瘍16例 Adjuvant chemotherapy with low-dose cisplatin following surgery for malignant tumors in dogs: 16 cases 佐藤敏彦 他 ―■原著 イヌの上顎および下顎に発生した高分化型線維 肉腫に対する局所療法:31 cases (1998-2007) Local Treatment for Canine Well-di!erentiated Maxillary and Mandibular Fibrosarcoma : 31 cases (1998-2007) 信田卓男 他 ―■短報 抜歯により病期が進行したと考えられるイヌの 口腔扁平上皮癌の2例 Advancement of oral squamous cell carcinoma due to careless tooth extraction : Two canine cases 石川剛司 他 Journal of Japan Veterinary Cancer Society November 2010 Jornal of Jpan Verinary C acer Sciety Vlum e 1 N um er 1 Jauary 201pp1-25 日 本 獣 医 が ん 学 会 雑 誌

[1]  D. Knapp,et al.  Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. , 2007, Journal of the American Veterinary Medical Association.

[2]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence , 2000 .

[3]  P. Bonney,et al.  Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. , 1998, Journal of the American Animal Hospital Association.

[4]  M. Gebhardt,et al.  Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma , 1997 .

[5]  J. Verweij,et al.  Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours. , 1996, British Journal of Cancer.

[6]  G. Ogilvie,et al.  Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms. , 1993, Journal of the American Veterinary Medical Association.

[7]  W. Rand,et al.  Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). , 1992, Journal of the American Veterinary Medical Association.

[8]  W. Rand,et al.  Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). , 1992, Journal of the American Veterinary Medical Association.

[9]  J. P. Thompson,et al.  Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). , 1992, Journal of the American Veterinary Medical Association.

[10]  B. Madewell,et al.  Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). , 1991, Journal of the American Veterinary Medical Association.

[11]  G. Ogilvie,et al.  Amputation and cisplatin for treatment of canine osteosarcoma. , 1991, Journal of veterinary internal medicine.

[12]  B. Madewell,et al.  Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs. , 1990, Journal of veterinary internal medicine.

[13]  R. Weigel,et al.  Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975-1985). , 1989, Journal of the American Veterinary Medical Association.

[14]  C. Anderson,et al.  Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Couto,et al.  Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs. , 1988, Journal of the American Veterinary Medical Association.

[16]  A. R. Twardock,et al.  Evaluation of a short-term saline diuresis protocol for the administration of cisplatin. , 1988, American journal of veterinary research.

[17]  B. Slotman,et al.  Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy. , 1988, Anticancer research.

[18]  D. Knapp,et al.  Cisplatin therapy in 41 dogs with malignant tumors. , 1988, Journal of Veterinary Internal Medicine.

[19]  W. Hryniuk,et al.  Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. , 1987, Seminars in oncology.

[20]  D. Knapp,et al.  Cisplatin toxicity in cats. , 1987, Journal of veterinary internal medicine.

[21]  G. Rustin,et al.  A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Gehan,et al.  Dose‐response and dose‐survival advantage for high versus low‐dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study , 1984, Cancer.

[23]  Cunningham Jd.  Cisplatin in the treatment of head and neck squamous carcinoma. , 1983 .

[24]  R. Brodey,et al.  Results of surgical treatment in 65 dogs with osteosarcoma. , 1976, Journal of the American Veterinary Medical Association.

[25]  B. Brown,et al.  The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. , 1973, Cancer research.